Page last updated: 2024-12-08

cgp 12388

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

CGP 12388: RN given for (+-)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID183824
SCHEMBL ID11242739
MeSH IDM0283543

Synonyms (10)

Synonym
cgp 12388
4-[2-hydroxy-3-(propan-2-ylamino)propoxy]benzimidazol-2-one
108929-47-1
4-(3-(isopropylamino)-2-hydroxypropoxy)-2h-benzimidazol-2-one
2h-benzimidazol-2-one, 4-(3-(isopropylamino)-2-hydroxypropoxy)-
2h-benzimidazol-2-one,1,3-dihydro-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
SCHEMBL11242739
4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}-2h-benzimidazol-2-one
DTXSID90910927
AKOS040751087
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (25.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (62.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]